Genotypes | Patients | Controls | P a | P b | P c | OR (95% CI)d |
---|---|---|---|---|---|---|
 | N = 243 | N = 333 |  |  |  |  |
BRCA2, exon 2, -26G>A | Â | Â | Â | Â | Â | Â |
   G/G | 144 (59.3%) | 157 (47.1%) |  |  | - | 1.0 (referent) |
   G/A | 74 (30.5%) | 152 (45.6%) |  |  | 0.0005e | 0.5 (0.4–0.8) |
   A/A | 25 (10.3%) | 24 (7.2%) | 0.002, 0.116 | 0.001 | 0.677 | 1.1 (0.6–2.1) |
   G | 74.50% | 70.00% |  |  | 0.092 | 1.2 (1.0–1.6) |
p53, exon 4, codon 72 Arg>Pro | Â | Â | Â | Â | Â | Â |
   Pro/Pro | 48 (19.8%) | 97 (29.1%) |  |  | - | 1.0 (referent) |
   Pro/Arg | 109 (44.9%) | 160 (48.0%) |  |  | 0.119 | 1.4 (0.9–2.1) |
   Arg/Arg | 86 (35.4%) | 76 (22.8%) | 0.210, 0.521 | 0.001 | 0.0005e | 2.3 (1.4–3.6) |
   Pro | 42.20% | 53.20% |  |  | 0.0002e | 0.6 (0.5–0.8) |